De Candussio G, Franchi D, Manini G, Arossa W, Castello D
Int J Clin Pharmacol Res. 1986;6(5):403-7.
The duration of action of procaterol, a beta-2-adrenoceptor agonist with an entirely new chemical structure, was assessed, in comparison to that of salbutamol, by inhalation of 43 inhalation units of methacholine at time intervals of 1, 3, 5, 7, and 9 hours after intake of the drugs. Procaterol and salbutamol were given in a double-blind random fashion, on different days, to 12 asthmatic children; pulmonary function tests (FVC, FEV1, MEF50, MEF25), skeletal muscle tremor, and vital signs (heart rate and blood pressure) were measured. Although there was no statistical significant difference between procaterol and salbutamol, protection of large and medium airways lasted for about five hours, while normal small airway patency was still present at seven hours. It is concluded that procaterol can be a good alternative beta-2-adrenoceptor agonist when the oral route is needed.
与沙丁胺醇相比,通过在摄入药物后1、3、5、7和9小时的时间间隔吸入43个吸入单位的乙酰甲胆碱,评估了具有全新化学结构的β2肾上腺素能受体激动剂丙卡特罗的作用持续时间。丙卡特罗和沙丁胺醇以双盲随机方式,在不同日期给予12名哮喘儿童;测量肺功能测试(FVC、FEV1、MEF50、MEF25)、骨骼肌震颤和生命体征(心率和血压)。尽管丙卡特罗和沙丁胺醇之间没有统计学上的显著差异,但大中气道的保护持续约5小时,而7小时时小气道仍保持正常通畅。得出的结论是,当需要口服途径时,丙卡特罗可以是一种很好的替代β2肾上腺素能受体激动剂。